Clinical trial
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
NCT00363948 · Ono Pharmaceutical Co. Ltd, Industry · Completed
Key facts
| NCT number | NCT00363948 |
|---|---|
| Title | Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus |
| Official title | MK-0431/ONO-5435 Phase III Clinical Study - Metformin Add-On Study for Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Ono Pharmaceutical Co. Ltd, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Placebo, Sitagliptin phosphate |
| Enrollment | 188 |
| Start date | Aug 1, 2006 |
| Primary completion | Feb 1, 2008 |
| First posted | Aug 15, 2006 |
| Last update posted | Jun 13, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: